Orally bioavailable gpIIb/IIIa receptor antagonist ME-3230 profiled at Japanese meeting March 27, 2000
Genentech outlines clinical trial plan for TNKase in combination with leading antithrombotics March 23, 2000
Antiplatelet agents designed at Toray with affinity for thromboxane and prostanoid receptors March 23, 2000
AstraZeneca's P2T antagonist AR-C69931MX beneficial and safe for acute coronary syndromes March 15, 2000
RSS